Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 66.7%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Clonazepam vs carbamazepine

Adverse events during treatment period · people with newly diagnosed epilepsy

The review found no eligible studies for this question.

1 finding from 1 review

Clonazepam monotherapy for treating people with newly diagnosed epilepsy 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Clonazepam vs ethosuximide

Adverse events during treatment period · people with newly diagnosed epilepsy

The review found no eligible studies for this question.

1 finding from 1 review

Clonazepam monotherapy for treating people with newly diagnosed epilepsy 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Clonazepam vs carbamazepine

Proportion of participants with treatment‐emergent adverse events (TEAEs) ‐ Leading to discontinuation during the treatment period № of participants: 36 (1 RCT) · people with newly diagnosed epilepsy

It is very uncertain whether clonazepam changes proportion of participants with treatment‐emergent adverse events… compared with carbamazepine (very low certainty).

1 finding from 1 review

Clonazepam monotherapy for treating people with newly diagnosed epilepsy 2022 · Cochrane Headline outcomes only
RR 2.61 [0.8, 8.52]
Studies not reported
Very low